当前位置:
X-MOL 学术
›
Nat. Rev. Endocrinol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Nutraceuticals in 2017: Nutraceuticals in endocrine disorders
Nature Reviews Endocrinology ( IF 40.5 ) Pub Date : 2017-12-22 , DOI: 10.1038/nrendo.2017.169 Amanda J. Berberich , Robert A. Hegele
Nature Reviews Endocrinology ( IF 40.5 ) Pub Date : 2017-12-22 , DOI: 10.1038/nrendo.2017.169 Amanda J. Berberich , Robert A. Hegele
Nutraceuticals in 2017: Nutraceuticals in endocrine disorders
中文翻译:
2017年的营养保健品:内分泌疾病中的营养保健品
2017年的营养保健品:内分泌疾病中的营养保健品
更新日期:2017-12-22
Nutraceuticals in 2017: Nutraceuticals in endocrine disorders, Published online: 22 December 2017; doi:10.1038/nrendo.2017.169
Nutraceuticals are gaining legitimacy and their potential clinical role is expanding. Data from 2017 provides evidence for their possible use in type 2 diabetes mellitus, the metabolic syndrome, obesity, dyslipidaemia and osteoporosis. Ongoing high-quality research in this area might justify future selective implementation of nutraceuticals into general health practice.中文翻译:
2017年的营养保健品:内分泌疾病中的营养保健品
2017年的营养保健品:内分泌疾病中的营养保健品
2017年《营养保健品:内分泌疾病中的营养保健品》,在线发布:2017年12月22日; doi:10.1038 / nrendo.2017.169
营养保健品正变得越来越合法,其潜在的临床作用正在扩大。2017年的数据提供了其可能用于2型糖尿病,代谢综合征,肥胖症,血脂异常和骨质疏松症的证据。在这一领域正在进行的高质量研究可能证明将来有选择地将营养保健品应用到一般健康实践中是合理的。